"They briefly mentioned that they're planning an additional building and it raised some questions," Patrick O'Brien, a City Council member, tells GlobeSt.com. "Afterwards we heard that there was a master plan and we'd like to see it rather than approve this plan piecemeal."
Scott Young, spokesperson for AstraZeneca's R&D Boston confirms for GlobeSt.com that the company is planning for additional buildings here, next to the planned garage. "There are long-term plans for all kinds of scenarios," he says. "We are running through the approval process now for the garage."
AstraZeneca was formed in 1999 from a merger between Astra, a Swedish company, and Zeneca, a company based in England. The company is now headquartered in London and has offices all over the world.
Want to continue reading?
Become a Free ALM Digital Reader.
Once you are an ALM Digital Member, you’ll receive:
- Breaking commercial real estate news and analysis, on-site and via our newsletters and custom alerts
- Educational webcasts, white papers, and ebooks from industry thought leaders
- Critical coverage of the property casualty insurance and financial advisory markets on our other ALM sites, PropertyCasualty360 and ThinkAdvisor
Already have an account? Sign In Now
*May exclude premium content© 2024 ALM Global, LLC, All Rights Reserved. Request academic re-use from www.copyright.com. All other uses, submit a request to [email protected]. For more information visit Asset & Logo Licensing.
